Research Governance Sample Clauses

Research Governance. 16.46All employees of the Trust who engage in research and development activities as part of their practice are expected to adhere to the principles of research governance as described in the Department of Health Research Governance Framework for Health and Social Care or any superseding document. Employees must also comply with:
AutoNDA by SimpleDocs
Research Governance. The Trust manages all research in accordance with the requirements of the Department of Health Research Governance Framework for Health and Social Care 2001. As a Staffbank Member of the Trust you must comply with all reporting requirements, systems and duties of action put in place by the Trust to deliver research governance. If, in the course of your duties, you undertake any form of research you agree to make yourself familiar with the Research Governance Framework and agree to accept the responsibilities associated with your role that are outlined within it.
Research Governance. The Parties should note the contents of the Department of Health's guidance on Research Governance, available at; xxxx://xxx.xx.xxx.xx/assetRoot/04/10/89/65/04108965.pdf and adhere to good practice described therein. The Provider must consult with the Policy Officer, Neighbourhoods and Adult Services prior to participating or agreeing to participate in any research projects or consultation whether original fieldwork or desk top review to ensure that the proposal meets expected standards in the five areas of ethics, science, information, health and safety and finance.
Research Governance. ‌ Research governance is the process we use to ensure a project meets the highest standards. It includes the safety and quality of research, financial, legal and regulatory matters, and ethical approval. All BDHP partners are accountable for the research conducted under their auspices and have research governance offices responsible for the oversight of research projects. If you want to conduct a research project at a BDHP partner organisation, we recommend you contact their research ethics and governance office. If you’re not sure where to get started, contact us. HRECs and Research Governance Office details for BDHP partners
Research Governance. [Health Board/Trust name] manages all research in accordance with the requirements of the Research Governance Framework (Welsh Government, 2009). As an appointee of the Health Board/Trust, you must comply with all reporting requirements, systems and duties put in place by the Health Board/Trust to deliver Research Governance.
Research Governance. Lancashire Care NHS Trust manages all research in accordance with the requirements of the Research Governance Framework. As an employee of Lancashire Care NHS Trust you must comply with all reporting requirements, systems and duties of action put in place by the Trust to deliver research governance.
Research Governance 
AutoNDA by SimpleDocs

Related to Research Governance

  • Corporate Governance Ultimus shall provide the following services to the Trust and its Funds:

  • Corporate Governance Matters At the Closing, the Company shall deliver to Parent evidence reasonably satisfactory to Parent of the resignation of the directors of the Company and of any Subsidiary as agreed between Parent and the Company, effective at the Effective Time.

  • Governance (a) The HSP represents, warrants and covenants that it has established, and will maintain for the period during which this Agreement is in effect, policies and procedures:

  • Research Independence The Company acknowledges that each Underwriter’s research analysts and research departments, if any, are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriter’s research analysts may hold and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of its investment bankers. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against such Underwriter with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriter’s investment banking divisions. The Company acknowledges that the Representative is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short position in debt or equity securities of the Company.

  • Certain Governance Matters (a) Water Pik and ATI intend that until the third annual meeting of stockholders of Water Pik held following the Distribution Date, at least a majority of the members of the Board of Directors of Water Pik will at all times consist of persons who are also members of the Board of Directors of ATI. The initial members of the Board of Directors of Water Pik and the respective initial Classes of the Board in which they will serve are as follows: Class I: Charxxx X. Xxxxxxx, Xx. Jamex X. Xxxx Class II: Michxxx X. Xxxxxx Willxxx X. Xxxxx Class III: Robexx X. Xxxxxxx (Xxairman) W. Craix XxXxxxxxxx

  • Collaboration Management Promptly after the Effective Date, each Party will appoint a person who will oversee day-to-day contact between the Parties for all matters related to the management of the Collaboration Activities in between meetings of the JSC and will have such other responsibilities as the Parties may agree in writing after the Effective Date. One person will be designated by Merck (the “Merck Program Director”) and one person will be designated by Moderna (the “Moderna Program Director,”) together will be the “Program Directors”. Each Party may replace its Program Director at any time by notice in writing to the other Party. Any Program Director may designate a substitute to temporarily perform the functions of that Program Director by written notice to the other Party. The initial Program Directors will be: For Moderna: [***] For Merck: [***]

  • Research Support opioid abatement research that may include, but is not limited to, the following:

  • Research Analyst Independence The Company acknowledges that the Underwriters’ research analysts and research departments are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriters’ research analysts may hold views and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of their respective investment banking divisions. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriters’ investment banking divisions. The Company acknowledges that each of the Underwriters is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short positions in debt or equity securities of the companies that may be the subject of the transactions contemplated by this Agreement.

  • ETHICAL CONDUCT Seller's employees shall comply with the BorgWarner Supplier Code of Conduct articulated within the BorgWarner Supplier Manual. Compliance with these standards is a mandatory component of Buyer's purchase contracts worldwide and must also apply to Seller subcontractors. Both, the BorgWarner Supplier Code of Conduct and the BorgWarner Supplier Manual are incorporated by reference as part of the Purchase Order, are binding on the Seller, and Seller explicitly verifies to have read and accepted the BorgWarner Supplier Code of Conduct and the BorgWarner Supplier Manual.

  • Clinical Development Licensee will have sole responsibility for and sole decision making over the clinical development of any Product arising from the Research Program in the Field. Notwithstanding the foregoing, if Licensee wishes to conduct clinical development of a Development Candidate at Penn and Penn has the clinical expertise, interest and ability to run such a trial as assessed at Penn’s sole discretion, such a study will be conducted under a separate Clinical Trial Agreement to be negotiated by the Parties prior to initiation of such study. Such separate clinical trial agreement will include a detailed clinical development plan, including costs and time lines for conducting the Clinical Trial.

Time is Money Join Law Insider Premium to draft better contracts faster.